Highlights and Quick Summary
- Research and Development (R&D) Expenses Growth for the quarter ending December 31, 2022 was -16.62% (a -1200.66% decrease compared to previous quarter)
- Year-over-year quarterly Research and Development (R&D) Expenses Growth decreased by -178.1%
- Annual Research and Development (R&D) Expenses Growth for 2022 was -1.59% (a -107.37% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2021 was 21.57% (a -152.79% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2020 was -40.86% (a -48.91% decrease from previous year)
- Twelve month Research and Development (R&D) Expenses Growth ending December 31, 2022 was -1.59% (a -115.63% decrease compared to previous quarter)
- Twelve month trailing Research and Development (R&D) Expenses Growth decreased by -105.32% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| -1.59% | 10.17% | 15.61% | 29.91% |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Research and Development (R&D) Expenses Growth of Precigen, Inc.
Most recent Research and Development (R&D) Expenses Growthof PGEN including historical data for past 10 years.Interactive Chart of Research and Development (R&D) Expenses Growth of Precigen, Inc.
Precigen, Inc. Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | -16.62% | 1.51% | -9.33% | 21.28% | -1.59% |
| 2021 | 39.49% | 22.24% | 39.16% | -7.12% | 21.57% |
| 2020 | 159.63% | -60.37% | -66.45% | -57.95% | -40.86% |
| 2019 | -106.79% | -42.82% | -32.84% | -27.72% | -79.98% |
| 2018 | 4526.77% | 23.07% | 23.63% | 9.03% | 205.02% |
| 2017 | -84.37% | 25.61% | 19.86% | 32.19% | -2.64% |
| 2016 | 10.2% | 34.43% | 39.22% | -67.4% | -23.97% |
| 2015 | 48.51% | 45.43% | 41.2% | 557.71% | 150.04% |
| 2014 | 40.56% | 39.16% | 6.84% | 5.67% | 22.52% |
| 2013 | -12.63% | -39.5% | -6.4% | -5.37% | -24.82% |
| 2012 | 14.45% | 65.3% | – | – | -8.82% |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology